Safety and tolerability of cariprazine in patients with acute bipolar mania: pooled analysis of 3 phase II/III pivotal studies

被引：0
|
作者：
Yatham, L. N. [1 ]
Vieta, E. [2 ]
Lu, K. [3 ]
Nagy, K. [4 ]
Laszlovszky, I. [4 ]
Earley, W. [3 ]
Durgam, S. [3 ]
机构：
[1] Univ British Columbia, Dept Psychiat, Mood Disorders Clin Res Unit, Vancouver, BC, Canada
[2] Univ Barcelona, Dept Psychiat, Barcelona, Spain
[3] Forest Res Inst, Jersey City, NJ USA
[4] Gedeon Richter Plc, Budapest, Hungary
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70681-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.d.023
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 50 条
  • [1] Safety and tolerability of cariprazine in patients with acute bipolar mania: Pooled analysis of 3 phase II/III pivotal studies
    Yatham, L.
    Vieta, E.
    Lu, K.
    Nagy, K.
    Laszlovszky, I.
    Earley, W.
    Durgam, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 133 - 133
  • [2] Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies
    Earley, Willie
    Durgam, Suresh
    Lu, Kaifeng
    Debelle, Marc
    Laszlovszky, Istvan
    Vieta, Eduard
    Yatham, Lakshmi N.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 215 : 205 - 212
  • [3] Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
    Barabassy, Agota
    Sebe, Barbara
    Acsai, Karoly
    Laszlovszky, Istvan
    Szatmari, Balazs
    Earley, Willie R.
    Nemeth, Gyorgy
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 957 - 970
  • [4] Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies (vol 17, pg 957, 2021)
    Barabassy, A.
    Sebe, B.
    Acsai, K.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1481 - 1481
  • [5] The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
    Durgam, Suresh
    Starace, Anju
    Li, Dayong
    Migliore, Raffaele
    Ruth, Adam
    Nemeth, Gyoergy
    Laszlovszky, Istvan
    BIPOLAR DISORDERS, 2015, 17 (01) : 63 - 75
  • [6] The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
    Knesevich, M. A.
    Papadakis, K.
    Bose, A.
    Wang, Q.
    Korotzer, A.
    Laszlovszky, I.
    BIPOLAR DISORDERS, 2009, 11 : 54 - 54
  • [7] The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
    Knesevich, M.
    Papadakis, K.
    Bose, A.
    Andor, G.
    Laszlovszky, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S469 - S470
  • [8] Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies
    Earley, Willie
    Durgam, Suresh
    Lu, Kaifeng
    Laszlovszky, Istvan
    Debelle, Marc
    Kane, John M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (06) : 319 - 328
  • [9] A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression
    Earley, Willie R.
    Burgess, Maria
    Rekeda, Ludmyla
    Hankinson, Arlene
    McIntyre, Roger S.
    Suppes, Trisha
    Calabrese, Joseph R.
    Yatham, Lakshmi N.
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 263 : 386 - 395
  • [10] Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials
    Vieta, Eduard
    Durgam, Suresh
    Lu, Kaifeng
    Ruth, Adam
    Debelle, Marc
    Zukin, Stephen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (11) : 1882 - 1891
12345